Literature DB >> 23356199

Ten years single center experience in percutaneous transhepatic decompression of biliary tree in patients with malignant obstructive jaundice.

Jerzy Garcarek1, Jacek Kurcz, Maciej Guziński, Dariusz Janczak, Marek Sasiadek.   

Abstract

BACKGROUND: Percutaneous transhepatic biliary drainage (PTBD) is a method of biliary tree decompression, applied as palliative treatment in patients with malignant biliary tree critical stenosis/obstruction, but also as a potentially curative treatment in patients with non-malignant biliary tree stenosis. Novel instrumentation dedicated to PTBD has been designed in recent years, which makes it possible to perform more advanced procedures in patients with severe extensive malignant biliary tree stenosis/obstruction.
OBJECTIVES: The first primary goal of the study was to compare both the rate and types of short- and long-term complications in patients who had undergone PTBD between 2000 and 2006 with patients treated between 2007 and 2011. The second primary goal of the study was to work out an original algorithm of efficient management in patients undergoing PTBD. An additional goal was to assess the efficacy of PTBD and the overall survival of the patients.
MATERIAL AND METHODS: One-hundred twenty-eight consecutive PTBD procedures performed between 2000 and 2006 in patients with malignant biliary jaundice were analyzed retrospectively. Similarly, retrospective analysis of 73 consecutive procedures in patients with malignant biliary jaundice performed between 2007 and 2011 was carried out. Subsequently, the results of both subsets were compared to each other. The PTBD procedure was guided fluoroscopy each time. PTBD involved external biliary drainage and/or stenting of the strictured/occluded segments of extra- and intrahepatic biliary ducts.
RESULTS: The analysis demonstrated a statistically significant decrease in the overall incidence of short- and long-term complications in patients undergoing PTBD in 2007-2011 in comparison to the subset treated in 2000-2006. Among the early complications, a significant decrease in sub- and pericapsular contrasted bile leaks was shown. The evaluation of long-term complications demonstrated lower incidence of the falling out of the draining catheter. The implementation of novel instrumentation made it possible to perform biliary stenting in 63.7% cases of common bile duct (CBD) obstruction (vs. 37.5% in procedures carried out in 2000-2006). However, no statistically significant difference in survival between the two analyzed subsets was demonstrated.
CONCLUSIONS: The analysis of rate and types of complications made it possible to establish authors own algorithm of management in different types of biliary obstructions and strictures. The modification of procedure technique, pos-tinterventional management and usage of the new generation of low-profile instrumentation for percutaneous access dedicated to PTBD has resulted in a significant reduction of the complication rate in the last 5 years. Higher frequency of CBD stenting improves the quality of life in this subset of patients.

Entities:  

Mesh:

Year:  2012        PMID: 23356199

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  17 in total

Review 1.  Endoscopic Ultrasound-Guided Biliary Drainage: A Systematic Review and Meta-Analysis.

Authors:  Muhammad Ali Khan; Ali Akbar; Todd H Baron; Sobia Khan; Mehmat Kocak; Yaseen Alastal; Tariq Hammad; Wade M Lee; Aijaz Sofi; Everson L A Artifon; Ali Nawras; Mohammad Kashif Ismail
Journal:  Dig Dis Sci       Date:  2015-10-30       Impact factor: 3.199

2.  Rescue EUS-guided intrahepatic biliary drainage for malignant hilar biliary stricture after failed transpapillary re-intervention.

Authors:  Kosuke Minaga; Mamoru Takenaka; Masayuki Kitano; Yasutaka Chiba; Hajime Imai; Kentaro Yamao; Ken Kamata; Takeshi Miyata; Shunsuke Omoto; Toshiharu Sakurai; Tomohiro Watanabe; Naoshi Nishida; Masatoshi Kudo
Journal:  Surg Endosc       Date:  2017-04-19       Impact factor: 4.584

3.  Evolution in the utilization of biliary interventions in the United States: results of a nationwide longitudinal study from 1998 to 2013.

Authors:  Robert J Huang; Nirav C Thosani; Monique T Barakat; Abhishek Choudhary; Alka Mithal; Gurkirpal Singh; Saurabh Sethi; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2017-01-04       Impact factor: 9.427

4.  Therapeutic Endoscopic Ultrasound.

Authors:  Danny Cheriyan; Jorge V Obando
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-07

5.  Percutaneous transhepatic biliary drainage and stenting for malignant obstructive jaundice: A report of two cases.

Authors:  Jin-Hui Shao; Hai-Xing Fang; Guo-Wei Li; Jia-Sheng He; Bao-Quan Wang; Jun-Hui Sun
Journal:  Exp Ther Med       Date:  2015-08-24       Impact factor: 2.447

Review 6.  Endoscopic ultrasound-guided biliary drainage as an alternative to percutaneous drainage and surgical bypass.

Authors:  Varayu Prachayakul; Pitulak Aswakul
Journal:  World J Gastrointest Endosc       Date:  2015-01-16

7.  Prediction of Survival Following Percutaneous Biliary Drainage for Malignant Biliary Obstruction.

Authors:  Wa'el Tuqan; Ayoub Innabi; Alia Alawneh; Fadi Abu Farsakh; Maan Al-Khatib
Journal:  J Transl Int Med       Date:  2017-06-30

8.  Hepato-biliary-enteric stent drainage as palliative treatment for proximal malignant obstructive jaundice.

Authors:  Hao Pan; Zhang Liang; Tian-sheng Yin; Yan Xie; De-wei Li
Journal:  Med Oncol       Date:  2014-01-24       Impact factor: 3.064

9.  Percutaneous Intraductal Microwave Ablation and Self-expandable Metallic Stenting: A New Treatment Method for Malignant Extrahepatic Biliary Obstruction.

Authors:  Rıdvan Pekçevik; Ömür Ballı
Journal:  Cardiovasc Intervent Radiol       Date:  2020-11-03       Impact factor: 2.740

10.  CIRSE Standards of Practice on Percutaneous Transhepatic Cholangiography, Biliary Drainage and Stenting.

Authors:  Marco Das; Christiaan van der Leij; Marcus Katoh; Daniel Benten; Babs M F Hendriks; Adam Hatzidakis
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-29       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.